News

By Vijay Kumar Malesu New research shows that early switching to camizestrant based on ctDNA detection of ESR1 mutations can ...
Breakthrough nanovaccine uses tumor cell membranes and immune-boosting polymers to enhance personalized cancer immunotherapy, ...